MOLECULAR GENETICS OF EMBRYOGENESIS IN C. ELEGANS
MOLECULAR GENETICS OF EMBRYOGENESIS IN C. ELEGANS
批准号:
3316199
负责人:
Dan Thomas Stinchcomb
金额:
$8.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1987-09-30
中文摘要
自二十世纪初以来,胚胎学家已经知道了很多
英文摘要
Since the early twentieth century, embryologists have known that much of
early development is controlled by information in the cytoplasm of the
egg. Maternal effect genes encode that information; their function is
required during oogenesis for embryogenesis to occur. One means of
studying the nature and function of maternal information is to isolate
maternal effect genes. The DNA sequences thus isolated can be used as
probes to study the molecular basis of interactions between the egg
cytoplasm and the zygotic nucleus during embryogenesis.
Caenorhabditis elegans, due to its defined cell lineage, physiology, and
genetics, has been widely used for studies of early development. Several
maternal effect lethal (mel) genes have been identified and characterized.
These genes will be isolated by DNA transformation. In preliminary
studies, the first important step in DNA transformation of C. elegans has
been achieved: the introduction and propagation of foreign DNA. The next
step is to demonstrate expression of the exogenously added sequences.
Concomitantly, DNA will be isolated that corresponds to defined genetic
regions surrounding and including mel genes. This DNA will be injected
into mel mutants; complementation of the mutant defect will define DNA that
encodes the gene.
Once isolated, mel gene sequences can be used to identify and characterize
RNA and protein products. The synthesis and metabolism of information
encoded by mel genes will provide insights into how genes establish
cytoplasmic information and then how the cytoplasm affects gene activity.
This recursive interrelationship between cytoplasm and nucleus is a central
issue in cellular behavior, development and differentiation. Thus,
understanding these interactions has implications for the treatment of
cellular and developmental defects and neoplasia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Technologies to Facilitate the Use of and Response to Vaccines
-
批准号:8317498
-
项目类别:
-
资助金额:$135.87万
-
财政年份:2011
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Development of Technologies to Facilitate the Use of and Response to Vaccines
-
批准号:8164633
-
项目类别:
-
资助金额:$183.31万
-
财政年份:2010
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Second Generation Dengue Vaccine
-
批准号:7747001
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2009
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Animal Models and Preclinical Development of a Chimeric Chikungunya Vaccine
-
批准号:7688232
-
项目类别:
-
资助金额:$15.34万
-
财政年份:2008
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
MVA-based vaccines against highly pathogenic avian influenza
-
批准号:7277467
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2007
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
MVA-based vaccines against highly pathogenic avian influenza
-
批准号:7416626
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2007
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Preclinical development of a chimeric tetravalent dengue vaccine
-
批准号:7291529
-
项目类别:
-
资助金额:$119.52万
-
财政年份:2006
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Preclinical development of a chimeric tetravalent dengue vaccine
-
批准号:7681592
-
项目类别:
-
资助金额:$48.76万
-
财政年份:2006
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Mucosal modified vaccinina Ankara-based plaque vaccines
-
批准号:7052479
-
项目类别:
-
资助金额:$35.76万
-
财政年份:2006
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Preclinical development of a chimeric tetravalent dengue vaccine
-
批准号:7491487
-
项目类别:
-
资助金额:$77.2万
-
财政年份:2006
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Mucosal modified vaccinina Ankara-based plaque vaccines
-
批准号:7197322
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2006
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
Preclinical development of a chimeric tetravalent dengue vaccine
-
批准号:7134891
-
项目类别:
-
资助金额:$41.87万
-
财政年份:2006
-
负责人:Dan Thomas Stinchcomb
-
依托单位:
MOLECULAR GENETICS OF EMBRYOGENESIS IN C. ELEGANS
-
批准号:3316198
-
项目类别:
-
资助金额:$9.52万
-
财政年份:1984
-
负责人:Dan Thomas Stinchcomb
-
依托单位: